| Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT) (NCT04959435) | University Hospital, Clermont-Ferrand | 2022-01-10 |
| IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease) (NCT05128357) | Azienda Ospedaliero, Universitaria Pisana | 2021-11-16 |
| Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease (NCT04528082) | Amgen | 2021-09-09 |
| Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease . (NCT04105439) | Assiut University | 2021-07-01 |
| A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease (NCT04609397) | Tianjin Hemay Pharmaceutical Co., Ltd | 2020-11-30 |
| Rheumatology Patient Registry and Biorepository (NCT04402086) | Yale University | 2020-08-04 |
| Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases (NCT04530461) | faida agili | 2020-06-01 |
| Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic (NCT04403438) | Istanbul University | 2020-04-01 |
| Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease (NCT04126850) | Fakultas Kedokteran Universitas Indonesia | 2019-11-01 |
| Biomarkers of Common Eye Diseases (NCT04101604) | Sun Yat-sen University | 2019-09-26 |
| Erectile Dysfunction in Patients With Non Ocular Behçet's Disease (NCT04386824) | Antalya Training and Research Hospital | 2019-06-15 |
| Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. (NCT04402255) | Istanbul University | 2019-06-01 |
| Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease (NCT03837236) | Gazi University | 2019-02-08 |
| Behçet's Disease Overall Damage Index (NCT03803462) | University of Cagliari | 2017-08-01 |
| Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis (NCT03209219) | Peking Union Medical College Hospital | 2017-06-30 |
| Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease (NCT02648581) | Assistance Publique - Hôpitaux de Paris | 2017-06-14 |
| 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement (NCT02756650) | Novartis Pharmaceuticals | 2016-06-23 |
| A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease (NCT02505568) | Janssen Korea, Ltd., Korea | 2015-07-22 |
| Phase III Study in Refractory Behcet's Disease (NCT00995709) | Novartis Pharmaceuticals | 2009-10-01 |
| Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease (NCT00483184) | Nobel Pharmaceuticals | 2006-04-01 |